{"id":"W4417212566","doi":"10.1016/j.ygyno.2025.11.020","title":"Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review","year":2025,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health","keywords":"Food and drug administration; Gynecologic oncology; Clinical trial; Ovarian cancer; Clinical Practice; Drug; MEDLINE; Biomarker","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009660279,0.0006026438,0.001037616,0.003904111,0.0008365478,0.004201531,0.001166523,0.005291928,0.01206979],"category_scores_gemma":[0.03000358,0.0005127506,0.001486717,0.003966712,0.001043544,0.003608251,0.001630298,0.005616688,0.003612038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002778971,"about_ca_system_score_gemma":0.007318592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00304942,"about_ca_topic_score_gemma":0.00979023,"domain_scores_codex":[0.9950192,0.001146571,0.001036369,0.000395708,0.002093107,0.0003091146],"domain_scores_gemma":[0.9636728,0.01288957,0.006051492,0.0005155696,0.0143297,0.002540868],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001514199,0.00007142205,0.001382582,0.002404176,0.00008941142,0.0003450087,0.0001064775,0.0003339243,0.0007204939,0.00315404,0.4975922,0.493649],"study_design_scores_gemma":[0.00007258167,0.0001031939,0.001808742,0.002516934,0.0001052152,0.000758651,0.0001012218,0.0001541706,0.0002496141,0.001082039,0.9930253,0.00002231805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002418259,0.6943349,0.002050941,0.2465789,0.01779961,0.00009224812,0.0008039072,0.0003414042,0.03557994],"genre_scores_gemma":[0.02209811,0.8224744,0.006323699,0.1122587,0.02439726,0.0001251138,0.001564428,0.0001831821,0.01057515],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01206979,"threshold_uncertainty_score":0.05108905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04627822145111066,"score_gpt":0.447854859502691,"score_spread":0.4015766380515804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}